<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00147082</url>
  </required_header>
  <id_info>
    <org_study_id>01-024</org_study_id>
    <nct_id>NCT00147082</nct_id>
  </id_info>
  <brief_title>Leukocyte Function in Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>Leukocyte Migration and Differentiation in COPD Patients Compared to Healthy Smokers and Healthy Non-smoking Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the mechanisms whereby leukocytes are recruited to
      the lung in chronic obstructive pulmonary disease (COPD) and cause tissue destruction. The
      hypothesis is that in COPD more leukocytes enter the lung and it is these cells that are
      responsible for the degradation of lung tissue. We, the researchers at Imperial College
      London, will isolate leukocytes from the blood of patients with COPD, healthy smokers and
      normal subjects and measure the movement of the leukocytes to chemoattractants. We will
      examine further, which cell surface receptors are responsible for this trafficking of cells.
      Furthermore, the differentiation of these cells in vitro will be compared with cells from
      healthy smokers and normal subjects. Specifically, the expression of enzymes that are
      responsible for tissue destruction and the cell surface receptors on these cells will be
      investigated. The objective is to identify the mechanisms whereby leukocytes from COPD
      patients behave differently to cells from healthy smokers and normal subjects with a view to
      identify novel targets for drug therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chemotaxis experiments will be performed in order to ascertain the migratory characteristics
      of leukocytes towards specific chemoattractants. Comparisons of cells from different subjects
      will be compared. In addition, the effects of various pharmaceutical interventions on this
      mechanism will also be addressed and compared within subject groups. In some experiments,
      cells will be differentiated in vitro and their cellular expression and regulation of
      inflammatory mediators and chemoattractants examined. Again comparisons will be made between
      subject groups and the efficacy of various pharmacological agents on these cells
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2001</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Effective Concentration (EC 50) of GRO Alpha</measure>
    <time_frame>2 hours</time_frame>
    <description>Migration response of PBMC to Chemokine EC 50 represents the concentration of a drug that is required for 50% inhibition in vitro</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective Concentration of IL-8</measure>
    <time_frame>2 hours</time_frame>
    <description>Migration response of PBMC to Chemokine EC 50 represents the concentration of a drug that is required for 50% inhibition in vitro</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effective Concentration of MCP-1</measure>
    <time_frame>2 hours</time_frame>
    <description>Migration response of PBMC to Chemokine</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>COPD</condition>
  <condition>Emphysema</condition>
  <condition>Chronic Bronchitis</condition>
  <arm_group>
    <arm_group_label>COPD</arm_group_label>
    <description>Patients with COPD - no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Smokers without COPD</arm_group_label>
    <description>Smokers without COPD - no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-smokers</arm_group_label>
    <description>Non-smokers with no history of respiratory disease - no intervention</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had taken inhaled or oral steroids or who had suffered an exacerbation of
        their airway disease in the previous 6 weeks were excluded.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Non-Smoking Subjects. All normal volunteers will meet the following criteria:

               -  Age 21-70 years.

               -  No history of respiratory or allergic disease.

               -  Normal baseline spirometry as predicted for age, sex and height.

               -  Non-smokers.

               -  No history of upper respiratory tract infection in the preceding six weeks.

               -  Not taking regular medication

          -  COPD Subjects. COPD is diagnosed according to American Thoracic Society, European
             Respiratory Society and British Thoracic Society guidelines. All COPD volunteers will
             meet the following criteria:

               -  Age between 40-75 years.

               -  A smoking history of at least 20 pack years. (1 pack year = 20 packs of
                  cigarettes per day for 1 year)

               -  Forced expiratory volume at 1 second : Forced vital capacity (FEV1:FVC) ratio of
                  &lt;0.7, post-bronchodilator FEV1 of &lt;85% predicted, reversibility with inhaled
                  beta2-agonist of &lt;15% of predicted FEV1: all three criteria are required.

               -  Current smokers or smokers who had ceased smoking for at least 6 months.

               -  No history of exacerbation, oral steroid or antibiotic use within the preceding 6
                  weeks.

               -  Normal serum alpha-1 antitrypsin level.

               -  No history of other respiratory or allergic disease.

               -  No evidence of atopy on skin prick testing to common aeroallergens (grass pollen,
                  cat hair, house dust mite or Aspergillus fumigatus

          -  Healthy Smokers. All healthy smoking volunteers in trials will meet the following
             criteria:

               -  Age 21-70 years.

               -  Smoking history of at least 10 pack years. (1 pack year = 10 packs of cigarettes
                  per day for 1 year).

               -  No history of respiratory or allergic disease.

               -  Normal baseline spirometry as predicted for age, sex and height.

               -  No history of upper respiratory tract infection in the preceding six weeks.

               -  Not taking regular medication.

        Exclusion Criteria:

        Subjects will not be included in this study if they meet any of the following exclusion
        criteria:

          -  Clinically significant findings in the medical history or on physical examination
             other than those of COPD in the COPD group.

          -  Pregnant women or mothers who are breastfeeding.

          -  Subjects who are unable to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louise E Donnelly, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Brompton Hospital/NHLI Imperial College London</name>
      <address>
        <city>London</city>
        <zip>SW3 6LY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Traves SL, Smith SJ, Barnes PJ, Donnelly LE. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2. J Leukoc Biol. 2004 Aug;76(2):441-50. Epub 2004 May 20.</citation>
    <PMID>15155777</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2005</study_first_posted>
  <results_first_submitted>November 6, 2019</results_first_submitted>
  <results_first_submitted_qc>December 4, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 5, 2019</results_first_posted>
  <last_update_submitted>December 4, 2019</last_update_submitted>
  <last_update_submitted_qc>December 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chemokine</keyword>
  <keyword>chemokine receptor</keyword>
  <keyword>neutrophil</keyword>
  <keyword>lymphocyte</keyword>
  <keyword>monocyte</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Bronchitis, Chronic</mesh_term>
    <mesh_term>Emphysema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>COPD</title>
          <description>Patients with COPD - no intervention</description>
        </group>
        <group group_id="P2">
          <title>Smokers Without COPD</title>
          <description>Smokers without COPD - no intervention</description>
        </group>
        <group group_id="P3">
          <title>Non-smokers</title>
          <description>Non-smokers with no history of respiratory disease - no intervention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="33"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="33"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>COPD</title>
          <description>Patients with COPD - no intervention</description>
        </group>
        <group group_id="B2">
          <title>Smokers Without COPD</title>
          <description>Smokers without COPD - no intervention</description>
        </group>
        <group group_id="B3">
          <title>Non-smokers</title>
          <description>Non-smokers with no history of respiratory disease - no intervention</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="30"/>
            <count group_id="B4" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="33"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" spread="10"/>
                    <measurement group_id="B2" value="40" spread="12"/>
                    <measurement group_id="B3" value="34" spread="8"/>
                    <measurement group_id="B4" value="47.45" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="33"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="33"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking History</title>
          <units>pack/years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="33"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48" spread="27"/>
                    <measurement group_id="B2" value="21" spread="16"/>
                    <measurement group_id="B3" value="0" spread="0"/>
                    <measurement group_id="B4" value="24.7" spread="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>FEV1 (% predicted)</title>
          <units>% predicted</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="37"/>
                    <count group_id="B2" value="33"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47" spread="15"/>
                    <measurement group_id="B2" value="93" spread="21"/>
                    <measurement group_id="B3" value="102" spread="14"/>
                    <measurement group_id="B4" value="78.7" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Effective Concentration (EC 50) of GRO Alpha</title>
        <description>Migration response of PBMC to Chemokine EC 50 represents the concentration of a drug that is required for 50% inhibition in vitro</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>COPD</title>
            <description>Patients with COPD - no intervention</description>
          </group>
          <group group_id="O2">
            <title>Smokers Without COPD</title>
            <description>Smokers without COPD - no intervention</description>
          </group>
          <group group_id="O3">
            <title>Non-smokers</title>
            <description>Non-smokers with no history of respiratory disease - no intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Effective Concentration (EC 50) of GRO Alpha</title>
          <description>Migration response of PBMC to Chemokine EC 50 represents the concentration of a drug that is required for 50% inhibition in vitro</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.9"/>
                    <measurement group_id="O2" value="0.9" spread="0.2"/>
                    <measurement group_id="O3" value="0.6" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>p values were calculated</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.05</p_value>
            <p_value_desc>The threshold for significance was p&lt;0.05</p_value_desc>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effective Concentration of IL-8</title>
        <description>Migration response of PBMC to Chemokine EC 50 represents the concentration of a drug that is required for 50% inhibition in vitro</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>COPD</title>
            <description>Patients with COPD - no intervention</description>
          </group>
          <group group_id="O2">
            <title>Smokers Without COPD</title>
            <description>Smokers without COPD - no intervention</description>
          </group>
          <group group_id="O3">
            <title>Non-smokers</title>
            <description>Non-smokers with no history of respiratory disease - no intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Effective Concentration of IL-8</title>
          <description>Migration response of PBMC to Chemokine EC 50 represents the concentration of a drug that is required for 50% inhibition in vitro</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="0.1"/>
                    <measurement group_id="O2" value="1.4" spread="0.4"/>
                    <measurement group_id="O3" value="0.8" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>p value was calculated</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.05</p_value>
            <p_value_desc>The p value (&lt;0.05) was the threshold for significance</p_value_desc>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Effective Concentration of MCP-1</title>
        <description>Migration response of PBMC to Chemokine</description>
        <time_frame>2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>COPD</title>
            <description>Patients with COPD - no intervention</description>
          </group>
          <group group_id="O2">
            <title>Smokers Without COPD</title>
            <description>Smokers without COPD - no intervention</description>
          </group>
          <group group_id="O3">
            <title>Non-smokers</title>
            <description>Non-smokers with no history of respiratory disease - no intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Effective Concentration of MCP-1</title>
          <description>Migration response of PBMC to Chemokine</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.4"/>
                    <measurement group_id="O2" value="0.2" spread="0.2"/>
                    <measurement group_id="O3" value="0.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The p value was calculated</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.05</p_value>
            <p_value_desc>The p value (&lt;0.05) was the threshold for significance</p_value_desc>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>COPD</title>
          <description>Patients with COPD - no intervention</description>
        </group>
        <group group_id="E2">
          <title>Smokers Without COPD</title>
          <description>Smokers without COPD - no intervention</description>
        </group>
        <group group_id="E3">
          <title>Non-smokers</title>
          <description>Non-smokers with no history of respiratory disease - no intervention</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Louise Donnelly</name_or_title>
      <organization>Imperial College London</organization>
      <phone>+442075947895</phone>
      <email>l.donnelly@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

